{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:45:04Z","timestamp":1793630704312,"version":"4.5.1"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Acute myeloid leukemia (AML) is a group of genetically and clinically heterogeneous malignancies characterized by clonal expansion of immature myeloid progenitors and profound disruption of normal hematopoiesis. Emerging evidence suggests that alterations in cellular homeostasis shape cancer progression. However, the mechanisms underlying AML progression remain largely unclear. Here, we identify lysophosphatidylcholine acyltransferase 3 (LPCAT3), a key enzyme of the Lands\u2019 cycle, as a critical regulator of AML progression. Analysis of public transcriptomic datasets and patient-derived CD34\n                      <jats:sup>+<\/jats:sup>\n                      cells revealed robust LPCAT3 overexpression in AML and an association between high LPCAT3 levels and inferior overall AML patient survival. Suppression of LPCAT3 by shRNA or CRISPR\u2013Cas9 in MOLM-13 and THP-1 cells markedly impaired proliferation, induced apoptosis, and caused G0\/G1 cell-cycle arrest. Conversely, enforced overexpression promoted cell survival. In xenograft murine models, LPCAT3 depletion reduced leukemic burden. RNA-seq following LPCAT3 loss showed that genes differentially expressed were significantly enriched in granulocyte chemotaxis\u2013related pathways, suggesting a role of LPCAT3 in modulation of leukemic differentiation programs and microenvironmental interactions. Collectively, these data established that LPCAT3 as a previously unrecognized mediator of AML cell fitness and as a potential therapeutic target.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bs9.0000000000000296","type":"journal-article","created":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:04:22Z","timestamp":1793628262000},"page":"e00296","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["LPCAT3 is essential for leukemia progression and represents a therapeutic vulnerability in AML"],"prefix":"10.1097","volume":"8","author":[{"given":"Mutian","family":"Cao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Cong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Hao","sequence":"additional","affiliation":[{"name":"Haihe Laboratory of Cell Ecosystem, Tianjin Medical University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyi","family":"Ling","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Yuan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Chu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"R1-20261102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML.","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R2-20261102","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2021011304","article-title":"Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal.","volume":"139","author":"Estey","year":"2022","journal-title":"Blood"},{"key":"R3-20261102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","article-title":"Extinguishing the embers: targeting AML metabolism.","volume":"27","author":"Culp-Hill","year":"2021","journal-title":"Trends Mol Med"},{"key":"R4-20261102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.stem.2025.01.013","article-title":"Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation.","volume":"32","author":"Song","year":"2025","journal-title":"Cell Stem Cell"},{"key":"R5-20261102","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","article-title":"Phospholipid remodeling in physiology and disease.","volume":"81","author":"Wang","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"R6-20261102","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases.","volume":"20","author":"Law","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R7-20261102","doi-asserted-by":"crossref","first-page":"122211","DOI":"10.1016\/j.envpol.2023.122211","article-title":"G protein-coupled estrogen receptor activation by bisphenol-A disrupts lipid metabolism and induces ferroptosis in the liver.","volume":"334","author":"He","year":"2023","journal-title":"Environ Pollut"},{"key":"R8-20261102","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/ars.2024.0793","article-title":"Peroxiredoxin 6: a regulatory target in cellular senescence and age-related diseases.","volume":"43","author":"Wang","year":"2025","journal-title":"Antioxid Redox Signal"},{"key":"R9-20261102","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/antiox7120172","article-title":"The role of peroxiredoxin 6 in cell signaling.","volume":"7","author":"Arevalo","year":"2018","journal-title":"Antioxidants"},{"key":"R10-20261102","doi-asserted-by":"crossref","first-page":"102256","DOI":"10.1016\/j.tranon.2024.102256","article-title":"LPCAT3 regulates the proliferation and metastasis of serous ovarian cancer by modulating arachidonic acid.","volume":"52","author":"Wen","year":"2025","journal-title":"Transl Oncol"},{"key":"R11-20261102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fsi.2022.05.003","article-title":"Lysophosphatidylcholine acyltransferase 3 (LPCAT3) mediates palmitate-induced inflammation in macrophages of large yellow croaker (Larimichthys crocea).","volume":"126","author":"Ding","year":"2022","journal-title":"Fish Shellfish Immunol"},{"key":"R12-20261102","first-page":"117","article-title":"Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation.","volume":"55","author":"Jiachun","year":"2022","journal-title":"Acta Biochim Biophys Sin"},{"key":"R13-20261102","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/antiox13091079","article-title":"Dietary organic zinc supplementation modifies the oxidative genes via ROR\u03b3 and epigenetic regulations in the ileum of broiler chickens exposed to high-temperature stress.","volume":"13","author":"Adam","year":"2024","journal-title":"Antioxidants"},{"key":"R14-20261102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.freeradbiomed.2025.02.015","article-title":"Deuterium-reinforced polyunsaturated fatty acids protect against muscle atrophy by STZ-induced diabetic mice.","volume":"230","author":"Eshima","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"R15-20261102","doi-asserted-by":"crossref","first-page":"e008554","DOI":"10.1136\/jitc-2023-008554","article-title":"Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-\u03b3-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors.","volume":"12","author":"Tao","year":"2024","journal-title":"J ImmunoTher Cancer"},{"key":"R16-20261102","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/ars.2023.0237","article-title":"LPCAT3 is transcriptionally regulated by YAP\/ZEB\/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity.","volume":"39","author":"Cui","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"R17-20261102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-024-02198-2","article-title":"Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins.","volume":"24","author":"Freitas-Cortez","year":"2025","journal-title":"Mol Cancer"},{"key":"R18-20261102","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.7150\/jca.71619","article-title":"Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer.","volume":"13","author":"Shao","year":"2022","journal-title":"J Cancer"},{"key":"R19-20261102","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cmet.2016.01.001","article-title":"Intestinal phospholipid remodeling is required for dietary-lipid uptake and survival on a high-fat diet.","volume":"23","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"R20-20261102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00011-025-02132-2","article-title":"LPCAT3-dependent remodeling of the phospholipids and lipid rafts is essential for vascular proinflammatory signaling and the development of atherosclerosis.","volume":"74","author":"Kondreddy","year":"2025","journal-title":"Inflamm Res"},{"key":"R21-20261102","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2013.10.002","article-title":"LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition.","volume":"18","author":"Rong","year":"2013","journal-title":"Cell Metab"},{"key":"R22-20261102","doi-asserted-by":"crossref","first-page":"807862","DOI":"10.3389\/fcell.2021.807862","article-title":"Integrated analysis of ferroptosis-related biomarker signatures to improve the diagnosis and prognosis prediction of ovarian cancer.","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R23-20261102","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s12672-025-02283-y","article-title":"LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress.","volume":"16","author":"Feng","year":"2025","journal-title":"Discov Oncol"},{"key":"R24-20261102","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-024-07387-7","article-title":"Ferroptosis as a promising targeted therapy for triple negative breast cancer.","volume":"207","author":"Mokhtarpour","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"R25-20261102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-024-00560-2","article-title":"Role of ferroptosis and ferroptosis-related long non\u2019coding RNA in breast cancer.","volume":"29","author":"Xiang","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"R26-20261102","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.21037\/tcr-22-985","article-title":"LPCAT3 is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis.","volume":"11","author":"Ke","year":"2022","journal-title":"Transl Cancer Res"},{"key":"R27-20261102","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/ijmm.2024.5356","article-title":"Research progress, challenges and perspectives of phospholipids metabolism in the LXR\u2011LPCAT3 signaling pathway and its relation to NAFLD (review).","volume":"53","author":"Wang","year":"2024","journal-title":"Int J Mol Med"},{"key":"R28-20261102","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"key":"R29-20261102","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1182\/bloodadvances.2017006247","article-title":"MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs.","volume":"1","author":"Maifrede","year":"2017","journal-title":"Blood Adv"},{"key":"R30-20261102","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41375-021-01481-1","article-title":"SETD5 modulates homeostasis of hematopoietic stem cells by mediating RNA polymerase II pausing in cooperation with HCF-1.","volume":"36","author":"Li","year":"2022","journal-title":"Leukemia"},{"key":"R31-20261102","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R32-20261102","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia.","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"R33-20261102","doi-asserted-by":"crossref","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","article-title":"BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis.","volume":"52","author":"G\u00edslason","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"R34-20261102","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13048-023-01140-2","article-title":"Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment.","volume":"16","author":"Huang","year":"2023","journal-title":"J Ovarian Res"},{"key":"R35-20261102","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40264-024-01436-2","article-title":"Targeting CCL24 in inflammatory and fibrotic diseases: rationale and results from three CM-101 phase 1 studies.","volume":"47","author":"Mor","year":"2024","journal-title":"Drug Saf"},{"key":"R36-20261102","doi-asserted-by":"crossref","first-page":"982130","DOI":"10.3389\/fphar.2022.982130","article-title":"The regulatory role of PDE4B in the progression of inflammatory function study.","volume":"13","author":"Su","year":"2022","journal-title":"Front Pharmacol"},{"key":"R37-20261102","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.4049\/jimmunol.0902149","article-title":"Role of the CXCR4\/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.","volume":"185","author":"Clements","year":"2010","journal-title":"J Immunol"},{"key":"R38-20261102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/cells14020105","article-title":"CCL24 and fibrosis: a narrative review of existing evidence and mechanisms.","volume":"14","author":"Greenman","year":"2025","journal-title":"Cells"},{"key":"R39-20261102","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-030-62658-7_7","article-title":"CCL24 signaling in the tumor microenvironment.","volume":"1302","author":"Lim","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"R40-20261102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/15548627.2023.2259732","article-title":"The lipid basis of cell death and autophagy.","volume":"20","author":"Lin","year":"2024","journal-title":"Autophagy"},{"key":"R41-20261102","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.2020006785","article-title":"BCL2 and MCL1 inhibitors for hematologic malignancies.","volume":"138","author":"Roberts","year":"2021","journal-title":"Blood"},{"key":"R42-20261102","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","article-title":"Copper metabolism in cell death and autophagy.","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"R43-20261102","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis.","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J"},{"key":"R44-20261102","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/biology10030184","article-title":"Lipid metabolism and ferroptosis.","volume":"10","author":"Lee","year":"2021","journal-title":"Biology"},{"key":"R45-20261102","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.3390\/ijms20153787","article-title":"Revisiting the role of LXRs in PUFA metabolism and phospholipid homeostasis.","volume":"20","author":"Jalil","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R46-20261102","doi-asserted-by":"crossref","first-page":"687778","DOI":"10.3389\/fgene.2021.687778","article-title":"Pan-cancer analysis of PIMREG as a biomarker for the prognostic and immunological role.","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Genet"},{"key":"R47-20261102","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41467-022-29000-5","article-title":"Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors.","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"R48-20261102","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1038\/s41467-024-47680-z","article-title":"The pRb\/RBL2-E2F1\/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry\/exit by paracrine mechanisms.","volume":"15","author":"Chang","year":"2024","journal-title":"Nat Commun"},{"key":"R49-20261102","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3390\/cancers13112701","article-title":"The critical role of TRIB2 in cancer and therapy resistance.","volume":"13","author":"Mayoral-Varo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R50-20261102","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11033-025-10487-2","article-title":"Studying the cellular efficacy and tolerability of using CRISPR-gRNA ribonucleoprotein (RNP) complex for in-vitro knockdown of TRIB2 in acute myeloid leukaemia (AML) cells as preliminary clinical evaluations.","volume":"52","author":"Tan","year":"2025","journal-title":"Mol Biol Rep"},{"key":"R51-20261102","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/s41388-019-1124-8","article-title":"Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.","volume":"39","author":"Filippou","year":"2020","journal-title":"Oncogene"},{"key":"R52-20261102","doi-asserted-by":"crossref","first-page":"e06328","DOI":"10.7554\/eLife.06328","article-title":"Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport.","volume":"4","author":"Hashidate-Yoshida","year":"2015","journal-title":"Elife"},{"key":"R53-20261102","doi-asserted-by":"crossref","first-page":"e135963","DOI":"10.1172\/JCI135963","article-title":"Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle.","volume":"131","author":"Ferrara","year":"2021","journal-title":"J Clin Invest"},{"key":"R54-20261102","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/leu.2015.66","article-title":"Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking.","volume":"29","author":"Ratajczak","year":"2015","journal-title":"Leukemia"},{"key":"R55-20261102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2004-04-1430","article-title":"Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem\/progenitor cells to an SDF-1 gradient.","volume":"105","author":"Wysoczynski","year":"2005","journal-title":"Blood"},{"key":"R56-20261102","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1021\/acschembio.2c00317","article-title":"LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from ferroptosis.","volume":"17","author":"Reed","year":"2022","journal-title":"ACS Chem Biol"},{"key":"R57-20261102","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications.","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"R58-20261102","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol"},{"key":"R59-20261102","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/ATVBAHA.112.300812","article-title":"Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.","volume":"33","author":"Ishibashi","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R60-20261102","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood"},{"key":"R61-20261102","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.3390\/ijms21218412","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4.","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R62-20261102","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2018.10.015","article-title":"SLAMF1\/CD150 in hematologic malignancies: silent marker or active player?","volume":"204","author":"Gordiienko","year":"2019","journal-title":"Clin Immunol"},{"key":"R63-20261102","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1189\/jlb.3MR0915-401R","article-title":"CD26\/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.","volume":"99","author":"Mortier","year":"2016","journal-title":"J Leukoc Biol"},{"key":"R64-20261102","doi-asserted-by":"crossref","first-page":"798604","DOI":"10.3389\/fcell.2021.798604","article-title":"Insights into bone marrow niche stability: an adhesion and metabolism route.","volume":"9","author":"Ashok","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R65-20261102","doi-asserted-by":"crossref","first-page":"113337","DOI":"10.1016\/j.intimp.2024.113337","article-title":"Inhibition of LPCAT3 exacerbates endoplasmic reticulum stress and HBV replication.","volume":"143","author":"Shi","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R66-20261102","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOL.0000000000000820","article-title":"The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease.","volume":"33","author":"Lagrost","year":"2022","journal-title":"Curr Opin Lipidol"}],"container-title":["Blood Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BS9.0000000000000296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:04:29Z","timestamp":1793628269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BS9.0000000000000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bs9.0000000000000296","relation":{},"ISSN":["2543-6368"],"issn-type":[{"value":"2543-6368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-10-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}